D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 57 Citations 9,302 130 World Ranking 7820 National Ranking 453

Overview

What is he best known for?

The fields of study he is best known for:

  • Organic chemistry
  • Enzyme
  • Catalysis

Abraha Habtemariam mainly focuses on Stereochemistry, Ruthenium, Ligand, Adduct and Pyridine. His Stereochemistry research is multidisciplinary, relying on both Redox, Ethylenediamine and Crystal structure. The concepts of his Ruthenium study are interwoven with issues in Cancer cell, Photochemistry, Molecule and Nucleobase.

His studies deal with areas such as Combinatorial chemistry and Reactivity as well as Ligand. His work deals with themes such as Tripeptide, Dimer, Nuclear magnetic resonance spectroscopy and DNA, which intersect with Adduct. As part of the same scientific family, Abraha Habtemariam usually focuses on Pyridine, concentrating on Hexamethylbenzene and intersecting with Denticity, Nicotinamide, Indane and Substitution reaction.

His most cited work include:

  • Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes (560 citations)
  • Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands (341 citations)
  • Organometallic Half-Sandwich Iridium Anticancer Complexes (225 citations)

What are the main themes of his work throughout his whole career to date?

Abraha Habtemariam mainly investigates Stereochemistry, Ruthenium, Ligand, Medicinal chemistry and Adduct. His work carried out in the field of Stereochemistry brings together such families of science as Chelation, Pyridine and Crystal structure. Abraha Habtemariam has included themes like Denticity, Photochemistry, Hydrolysis, Ethylenediamine and Hexamethylbenzene in his Ruthenium study.

His Ligand study incorporates themes from Reactivity and Metal. His Medicinal chemistry research incorporates elements of Formate, Catalysis, Bipyridine, Transfer hydrogenation and Aqueous solution. His work in Adduct addresses subjects such as Nuclear magnetic resonance spectroscopy, which are connected to disciplines such as Platinum.

He most often published in these fields:

  • Stereochemistry (57.04%)
  • Ruthenium (45.19%)
  • Ligand (38.52%)

What were the highlights of his more recent work (between 2014-2020)?

  • Stereochemistry (57.04%)
  • Medicinal chemistry (28.89%)
  • Ligand (38.52%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Stereochemistry, Medicinal chemistry, Ligand, Ruthenium and Cancer cell. He integrates Stereochemistry with Cisplatin in his study. His Medicinal chemistry study integrates concerns from other disciplines, such as Denticity, Formate, Adduct, Bipyridine and Aqueous solution.

His Ligand research incorporates themes from Pyridine, Cyclopentadienyl complex, Crystal structure, Metal and Transfer hydrogenation. His research in Ruthenium intersects with topics in Photochemistry, Group 2 organometallic chemistry and Dissociation. His Cancer cell research includes elements of HeLa, Oxidative phosphorylation, Cytotoxicity and Cancer research.

Between 2014 and 2020, his most popular works were:

  • Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design (129 citations)
  • Asymmetric transfer hydrogenation by synthetic catalysts in cancer cells (76 citations)
  • Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands. (75 citations)

In his most recent research, the most cited papers focused on:

  • Organic chemistry
  • Enzyme
  • Catalysis

The scientist’s investigation covers issues in Cancer cell, Stereochemistry, Ruthenium, Combinatorial chemistry and Ligand. His biological study spans a wide range of topics, including Apoptosis, Cancer research, Oxaliplatin and Bioinformatics. Abraha Habtemariam conducts interdisciplinary study in the fields of Stereochemistry and Blood serum through his works.

Specifically, his work in Ruthenium is concerned with the study of Osmium. The study incorporates disciplines such as Iodide, Cyclopentadienyl complex, Mechanism of action, Glutathione and Adduct in addition to Ligand. His Cyclopentadienyl complex research is multidisciplinary, incorporating elements of Chelation, Substituent, Transfer hydrogenation and Structural isomer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes

Yaw Kai Yan;Michael Melchart;Abraha Habtemariam;Peter J. Sadler.
Chemical Communications (2005)

628 Citations

Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands

Abraha Habtemariam;Michael Melchart;Rafael Fernandez;Simon Parsons.
Journal of Medicinal Chemistry (2006)

500 Citations

Controlling ligand substitution reactions of organometallic complexes: tuning cancer cell cytotoxicity.

F Y Wang;A Habtemariam;E P L van der Geer;R Fernandez.
Proceedings of the National Academy of Sciences of the United States of America (2005)

311 Citations

Organometallic Half-Sandwich Iridium Anticancer Complexes

Zhe Liu;Abraha Habtemariam;Ana M. Pizarro;Sally A. Fletcher.
Journal of Medicinal Chemistry (2011)

308 Citations

Catalytic organometallic anticancer complexes

Sarah J. Dougan;Abraha Habtemariam;Sarah E. McHale;Simon Parsons.
Proceedings of the National Academy of Sciences of the United States of America (2008)

308 Citations

Tuning the Reactivity of Osmium(II) and Ruthenium(II) Arene Complexes under Physiological Conditions

Anna F A Peacock;Abraha Habtemariam;Rafael Fernández;Victoria Walland.
Journal of the American Chemical Society (2006)

277 Citations

The Potent Oxidant Anticancer Activity of Organoiridium Catalysts

Zhe Liu;Isolda Romero-Canelón;Bushra Qamar;Jessica M. Hearn.
Angewandte Chemie (2014)

268 Citations

Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design

Joan J. Soldevila-Barreda;Isolda Romero-Canelón;Abraha Habtemariam;Peter J. Sadler.
Nature Communications (2015)

245 Citations

Use of chelating ligands to tune the reactive site of half-sandwich ruthenium(II)-arene anticancer complexes.

Rafael Fernández;Michael Melchart;Abraha Habtemariam;Simon Parsons.
Chemistry: A European Journal (2004)

229 Citations

Competition between glutathione and guanine for a ruthenium(II) arene anticancer complex : detection of a sulfenato intermediate

Fuyi Wang;Jingjing Xu;Abraha Habtemariam;Juraj Bella.
Journal of the American Chemical Society (2005)

220 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Abraha Habtemariam

Peter J. Sadler

Peter J. Sadler

University of Warwick

Publications: 128

Christian G. Hartinger

Christian G. Hartinger

University of Auckland

Publications: 103

Bernhard K. Keppler

Bernhard K. Keppler

University of Vienna

Publications: 93

Paul J. Dyson

Paul J. Dyson

École Polytechnique Fédérale de Lausanne

Publications: 90

Michael A. Jakupec

Michael A. Jakupec

University of Vienna

Publications: 60

Liang-Nian Ji

Liang-Nian Ji

Sun Yat-sen University

Publications: 58

Bruno Therrien

Bruno Therrien

University of Neuchâtel

Publications: 51

Hui Chao

Hui Chao

Sun Yat-sen University

Publications: 40

Zong-Wan Mao

Zong-Wan Mao

Sun Yat-sen University

Publications: 38

Vladimir B. Arion

Vladimir B. Arion

University of Vienna

Publications: 35

Viktor Brabec

Viktor Brabec

Czech Academy of Sciences

Publications: 31

Iztok Turel

Iztok Turel

University of Ljubljana

Publications: 30

Gérard Jaouen

Gérard Jaouen

Chimie ParisTech

Publications: 28

Rosario Scopelliti

Rosario Scopelliti

École Polytechnique Fédérale de Lausanne

Publications: 27

Angela Casini

Angela Casini

Technical University of Munich

Publications: 27

Gilles Gasser

Gilles Gasser

Chimie ParisTech

Publications: 27

Trending Scientists

Luciano Baresi

Luciano Baresi

Polytechnic University of Milan

Alon Lavie

Alon Lavie

Carnegie Mellon University

Daniel C. Robbins

Daniel C. Robbins

Microsoft (United States)

Dursun Delen

Dursun Delen

Oklahoma State University

Edwin L. Piner

Edwin L. Piner

Texas State University

Alvin L. Crumbliss

Alvin L. Crumbliss

Duke University

Kirsten Skarstad

Kirsten Skarstad

Oslo University Hospital

Jane M. Reid

Jane M. Reid

University of Aberdeen

Jerome Vinograd

Jerome Vinograd

California Institute of Technology

Dario Leister

Dario Leister

Ludwig-Maximilians-Universität München

Jun Nakayama

Jun Nakayama

Shinshu University

Liliane Schoofs

Liliane Schoofs

KU Leuven

W.O. van der Knaap

W.O. van der Knaap

University of Bern

Jonathan H. Sharp

Jonathan H. Sharp

University of Delaware

Ichiro Tayasu

Ichiro Tayasu

Kyoto University

Hiroyuki Kusuhara

Hiroyuki Kusuhara

University of Tokyo

Something went wrong. Please try again later.